With the emergence of new risks in the routine and complex surgical procedures, the threat of antibiotic resistance is increasingly attracting public awareness
The Data Protection debate has returned to the spotlight as global pharmaceutical companies renew their demand for stronger regulatory safeguards in India.
The Drug manufacturers sector could see a major regulatory change in the United States. The US FDA has proposed a new rule to simplify registration for certain companies using distributed manufacturing models.
India's Drug Deal Reform is set to tighten the country's public drug procurement system. The move aims to stop companies with canceled manufacturing licenses from securing government contracts. Officials believe the Drug Deal Reform will close...
Indian institutes and regulatory bodies are effectively taking steps in dengue preparedness and medical solutions for the issue
The new clearance on Navi Mumbai International Airport as a port for drug imports marks a significant development for India's pharmaceutical sector
The patient advocacy groups in India called for the incorporation of new cancer drugs into the NLEM,due to an increasing disparity between medical developments and public health care provisions
Indian healthcare sector transforms as pharmaceuticals step beyond traditional roles to make advanced treatments more accessible and affordable.
Telangana launches a new cancer drug plant, inaugurated by IT and Industries Minister Duddilla Sridhar Babu, which aims to boost the production of generic cancer drugs that will decrease the dependence on imports
India hosts the BRICS Heads in Guwahati, chaired by the Narcotics Control Bureau, and anti-drug agencies from BRICS nations to address the rising concerns over drug trafficking and substance abuse globally
, CDSCO.jpg)